Dolby Laboratories, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $8.1 Billion | 1/8 | DLB $8.1B |
CBZ $4.4B |
MMS $3.8B |
FA $3.4B |
AZZ $2.9B |
BV $1.4B |
CASS $605.1M |
CVEO $342.5M |
Gross Margin | 89% | 4/8 | CVEO 100% |
FA 100% |
CASS 94% |
DLB 89% |
BV 25% |
AZZ 24% |
MMS 23% |
CBZ 17% |
Profit Margin | 19% | 1/8 | DLB 19% |
CASS 9% |
CBZ 8% |
AZZ 8% |
MMS 6% |
BV 2% |
CVEO -3% |
FA -4% |
EBITDA margin | 20% | 3/8 | FA 55% |
AZZ 21% |
DLB 20% |
CBZ 15% |
MMS 8% |
BV 7% |
CASS 5% |
CVEO 4% |
Quarterly Revenue | $304.8 Million | 5/8 | MMS $1.3B |
BV $728.7M |
CBZ $438.9M |
AZZ $403.7M |
DLB $304.8M |
FA $199.1M |
CVEO $176.0M |
CASS $50.4M |
Quarterly Earnings | $58.6 Million | 2/8 | MMS $72.5M |
DLB $58.6M |
CBZ $35.1M |
AZZ $33.6M |
BV $16.6M |
CASS $4.6M |
CVEO -$5.1M |
FA -$8.9M |
Quarterly Free Cash Flow | $108.8 Million | 2/8 | MMS $131.9M |
DLB $108.8M |
FA $56.0M |
CBZ $41.1M |
AZZ $39.7M |
CVEO $28.4M |
CASS -$0 |
BV -$0 |
Trailing 4 Quarters Revenue | $1.3 Billion | 5/8 | MMS $5.3B |
BV $2.8B |
AZZ $1.9B |
CBZ $1.3B |
DLB $1.3B |
FA $755.6M |
CVEO $701.6M |
CASS $171.9M |
Trailing 4 Quarters Earnings | $261.8 Million | 2/8 | MMS $1.3B |
BV $728.7M |
CBZ $438.9M |
AZZ $403.7M |
DLB $304.8M |
FA $199.1M |
CVEO $176.0M |
CASS $50.4M |
Quarterly Earnings Growth | 538% | 1/8 | DLB 538% |
AZZ 25% |
MMS 23% |
CBZ 4% |
BV 1% |
CASS -45% |
CVEO -156% |
FA -182% |
Annual Earnings Growth | 348% | 1/8 | DLB 348% |
MMS 102% |
AZZ 10% |
CBZ 4% |
BV -27% |
CASS -37% |
CVEO -46% |
FA -88% |
Quarterly Revenue Growth | 5% | 3/8 | CBZ 7% |
AZZ 6% |
DLB 5% |
MMS 4% |
CASS 0% |
FA -1% |
BV -2% |
CVEO -4% |
Annual Revenue Growth | 7% | 3/8 | AZZ 20% |
MMS 10% |
DLB 7% |
FA 0% |
CVEO -3% |
BV -9% |
CASS -13% |
CBZ -18% |
Cash On Hand | $577.8 Million | 1/8 | DLB $577.8M |
CASS $349.7M |
FA $307.4M |
MMS $183.1M |
BV $140.4M |
CBZ $44.2M |
CVEO $17.9M |
AZZ $1.5M |
Short Term Debt | $12.2 Million | 3/8 | BV $24.9M |
CVEO $14.0M |
DLB $12.2M |
AZZ $7.4M |
FA $2.6M |
MMS -$0 |
CBZ -$0 |
CASS -$0 |
Long Term Debt | $34.8 Million | 7/8 | BV $865.1M |
FA $564.2M |
CBZ $335.8M |
MMS $97.2M |
CVEO $58.0M |
AZZ $38.5M |
DLB $34.8M |
CASS $0 |
PE | 30.83 | 4/8 | FA 701.38 |
CBZ 36.61 |
CASS 31.57 |
DLB 30.83 |
BV 28.87 |
AZZ 23.82 |
CVEO 16.29 |
MMS 12.51 |
PS | 6.34 | 1/8 | DLB 6.34 |
FA 4.55 |
CASS 3.52 |
CBZ 3.32 |
AZZ 1.54 |
MMS 0.72 |
BV 0.51 |
CVEO 0.49 |
PB | 3.27 | 2/8 | FA 3.74 |
DLB 3.27 |
AZZ 2.84 |
CASS 2.64 |
CBZ 2.59 |
MMS 2.08 |
CVEO 1.21 |
BV 0.79 |
PC | 13.97 | 5/8 | AZZ 1972.35 |
CBZ 98.63 |
MMS 20.97 |
CVEO 19.13 |
DLB 13.97 |
FA 11.19 |
BV 9.97 |
CASS 1.73 |
Liabilities to Equity | 0.26 | 8/8 | CASS 9.46 |
BV 1.26 |
MMS 1.24 |
AZZ 1.18 |
FA 0.80 |
CVEO 0.69 |
CBZ 0.48 |
DLB 0.26 |
ROA | 0.08 | 1/8 | DLB 8% | MMS 7% | CBZ 6% | AZZ 5% | CVEO 4% | CASS 1% | BV 1% | FA 0% |
ROE | 0.11 | 4/8 | MMS 17% |
CBZ 13% |
AZZ 12% |
DLB 11% |
CASS 8% |
CVEO 7% |
BV 4% |
FA 1% |
Current Ratio | 4.83 | 1/8 | DLB 4.83 |
CBZ 4.76 |
CVEO 2.47 |
FA 2.25 |
BV 2.11 |
AZZ 1.85 |
MMS 1.81 |
CASS 1.11 |
Quick Ratio | 0.90 | 1/8 | FA 701.38 |
CBZ 36.61 |
CASS 31.57 |
DLB 30.83 |
BV 28.87 |
AZZ 23.82 |
CVEO 16.29 |
MMS 12.51 |
Long Term Debt to Equity | 0.01 | 7/8 | BV} 0.68 |
FA} 0.61 |
CBZ} 0.36 |
CVEO} 0.21 |
MMS} 0.05 |
AZZ} 0.04 |
DLB} 0.01 |
CASS} 0.00 |
Debt to Equity | 0.02 | 7/8 | BV 0.70 |
FA 0.62 |
CBZ 0.36 |
CVEO 0.21 |
MMS 0.05 |
AZZ 0.03 |
DLB 0.02 |
CASS 0.00 |
Burn Rate | -10.68 | 7/8 | FA 9.59 |
BV 5.79 |
CVEO 1.64 |
AZZ -0.05 |
CBZ -2.04 |
MMS -2.67 |
DLB -10.68 |
CASS -76.13 |
Cash to Cap | 0.07 | 4/8 | CASS 0.58 |
BV 0.10 |
FA 0.09 |
DLB 0.07 |
CVEO 0.05 |
MMS 0.05 |
CBZ 0.01 |
AZZ 0.00 |
CCR | 1.86 | 1/8 | DLB 1.86 |
MMS 1.82 |
AZZ 1.18 |
CBZ 1.17 |
CVEO -5.58 |
FA -6.32 |
CASS |
BV |
EV to EBITDA | 126.24 | 1/8 | DLB} 126.24 |
CASS} 99.42 |
CBZ} 70.95 |
CVEO} 56.58 |
BV} 41.42 |
AZZ} 34.50 |
FA} 33.64 |
MMS} 33.59 |
EV to Revenue | 5.92 | 1/8 | DLB 5.92 |
FA 4.90 |
CBZ 3.54 |
AZZ 1.56 |
CASS 1.49 |
BV 0.78 |
MMS 0.71 |
CVEO 0.55 |